PlainPharmaWatch

CMS Open Payments · Program Year 2024

Iterative Scopes, Inc.

Iterative Scopes, Inc. reported $29,189.75 across General Payments, Research, and Ownership to 50 physicians and teaching hospitals across 50 transactions.

$29.2K
All-tracks total
50
Transactions
50
Recipients
+$27.8K
General Payments vs PY2023

Iterative Scopes, Inc. reported $29,189.75 across all CMS Open Payments tracks (General + Research + Ownership) to 50 physicians and teaching hospitals in Program Year 2024 - ranking #1476 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $29,189.75, averaging $583.79 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer iterative-scopes-inc Iterative Scopes, Inc.

$29.2K · #1476/1,925 · 0.0% industry · PY2024

  • TOT $29.2K
  • RANK #1476
  • SHARE 0.0%
  • TXN 50
  • RCP 50
  • CAT 2
  • GEN $29.2K
  • ΔGEN +$27.8K
  • TOP1 22.6%
  • PY 2024

Nearest volume peer: Gyder Surgical US Inc ($29.2K)

MY01 Inc.$29.5K3B Medical, Inc.$29.3KGyder Surgical US Inc$29.2KIterative Scopes, Inc. (this)$29.2KTheragen, Inc.$28.8K
All-tracks payment totals near Iterative Scopes, Inc. (CMS Open Payments PY2024)

Iterative Scopes, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Iterative Scopes, Inc.'s CMS-reported General Payments increased by $27.8K (+1948.4%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2023: ITERATIVE SCOPES, INC.PY2024: Iterative Scopes, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.4KPY2024$29.2K
PY2023
$1,425.00
PY2024
$29,189.75

What the Data Shows for Iterative Scopes, Inc.

In Program Year 2024, Iterative Scopes, Inc. reported $29,189.75 in payments to 50 physicians and teaching hospitals across 50 individual transactions, an average of $583.79 per transaction and $583.79 per recipient. That total places Iterative Scopes, Inc. at rank #1476 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $27.2K, accounting for 93.2% of this company's General Payments and 17 transactions.

General Payment Breakdown by Type

Iterative Scopes, Inc. made 2 types of general payments. "Consulting Fee" is the largest category at $27.2K, 93.2% of General Payments.

How Iterative Scopes, Inc. divides its payments

General-payment categories, ordered by reported total

1. Consulting Fee$27.2K2. Food and Beverage$2.0K
Payment Type Amount Transactions
Consulting Fee $27.2K 17
Food and Beverage $2.0K 33

Recipient Concentration in General Payments

The five largest recipient relationships account for $21,816.65 (74.7%) of $29,189.75 in this company's General Payments records across 26 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Iterative Scopes, Inc.

The five named recipients with the highest reported General Payments from this company

Neil Parikh$6.6KJodie Barkin$6.2KAasma Shaukat$5.9KBrooks Cash$1.9KDavid Hass$1.2K
  1. 1

    Neil Parikh

    $6,600.00 across 3 reported transactions

  2. 2

    Jodie Barkin

    $6,150.00 across 2 reported transactions

  3. 3

    Aasma Shaukat

    $5,929.65 across 8 reported transactions

  4. 4

    Brooks Cash

    $1,899.00 across 3 reported transactions

  5. 5

    David Hass

    $1,238.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Iterative Scopes, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Iterative Scopes, Inc..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Iterative Scopes, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Iterative Scopes, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.